Inicio/Acciones/RLAY

RLAY

USD

Relay Therapeutics Inc. Common Stock

$6.860+0.060 (0.882%)

Precio en Tiempo Real

Healthcare

Biotecnología

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$6.800

Máximo

$7.035

Mínimo

$6.770

Volumen

1.74M

Fundamentos de la Empresa

Capitalización de Mercado

1.2B

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

1.68M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $1.775Actual $6.860Máximo $7.64

Noticias Relacionadas

3 nov 2025 · 21:05

GlobeNewswire

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (NASDAQ:RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November

30 oct 2025 · 20:05

GlobeNewswire

Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025

CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (NASDAQ:RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational